In a 35‑year‑old Black female with microcytic anemia (mean corpuscular volume 74.3 fL, red cell distribution width 15.1 %), what does an iron level of 70 µg/dL and ferritin of 71 ng/mL indicate and what is the appropriate next diagnostic step?

Interpretation and Next Steps

With an iron level of 70 µg/dL and ferritin of 71 ng/mL in a 35-year-old Black female with microcytic anemia (MCV 74.3 fL, RDW 15.1%), iron deficiency is NOT definitively excluded and hemoglobinopathy screening with hemoglobin electrophoresis should be performed immediately.

Understanding These Laboratory Values

Your patient's ferritin of 71 ng/mL falls into a diagnostic gray zone. While this level is above the classic threshold for absolute iron deficiency (<15 ng/mL), it does not rule out iron deficiency in this clinical context 1. The guidelines are clear: ferritin levels between 30-100 ng/mL can still represent iron deficiency, particularly when inflammation is present 2, 3. More recent evidence suggests that ferritin <45 ng/mL provides optimal sensitivity-specificity balance for detecting iron deficiency in practice 3.

The elevated RDW (15.1%) is particularly important here—this suggests heterogeneous red cell populations and supports either iron deficiency or a combined deficiency state 1.

Critical Consideration: Race and Hemoglobinopathy Risk

The patient's Black ethnicity is diagnostically crucial. Microcytosis in Black patients frequently results from hemoglobinopathies, particularly thalassemia trait, which can present with similar laboratory findings 1. The guidelines explicitly warn against presuming iron deficiency as the cause in certain ethnic groups without laboratory confirmation 1.

Key distinguishing features to assess:

• Red blood cell count: If elevated (>5.0 million/µL) with microcytosis, thalassemia becomes more likely 1
• Degree of microcytosis: MCV of 74.3 fL with preserved hemoglobin suggests possible trait rather than severe deficiency
• Iron level of 70 µg/dL: This is not frankly low, making pure iron deficiency less certain

Algorithmic Approach to Next Steps

Step 1: Order Hemoglobin Electrophoresis Immediately

This is non-negotiable before proceeding with iron treatment or GI investigation 1, 3. You need to exclude beta-thalassemia trait (elevated HbA2 >3.5%) and other hemoglobinopathies. The guidelines state this should not be presumed without laboratory confirmation 1.

Step 2: Assess for Inflammation

Measure C-reactive protein (CRP) or ESR. If elevated, the ferritin threshold for excluding iron deficiency rises to 100 ng/mL 2, 4. With inflammation present and ferritin 30-100 ng/mL, you likely have combined iron deficiency and anemia of chronic disease 2, 4.

Step 3: Calculate Transferrin Saturation

If not already done, obtain total iron-binding capacity (TIBC) to calculate transferrin saturation. Transferrin saturation <16-20% supports iron deficiency even with borderline ferritin 2, 4, 5. This helps distinguish true iron deficiency from functional iron deficiency or anemia of chronic disease.

Step 4: Determine Need for GI Investigation

If hemoglobin electrophoresis is normal:

• In a 35-year-old premenopausal woman, menstrual blood loss is the most likely cause 1
• Take careful menstrual history (heavy periods, duration, clots)
• GI investigation is generally not warranted in premenopausal women with microcytic anemia unless there are GI symptoms, family history of GI malignancy, or failure to respond to iron therapy 3
• The threshold for GI investigation should be low only in men, postmenopausal women, or those with GI symptoms 3

If hemoglobin electrophoresis shows thalassemia trait:

• No iron supplementation needed unless true concurrent iron deficiency is proven
• No GI investigation required
• Genetic counseling if planning pregnancy

Common Pitfalls to Avoid

1. Do not assume iron deficiency based solely on microcytosis in a Black patient—hemoglobinopathy must be excluded first 1

2. Do not use ferritin >30 ng/mL to definitively exclude iron deficiency—the cutoff depends on inflammatory status 2, 3, 4

3. Do not initiate empiric iron therapy before hemoglobin electrophoresis—if thalassemia trait is present, iron supplementation is unnecessary and potentially harmful

4. Do not rush to GI investigation in a premenopausal woman—menstrual blood loss is by far the most common cause, and GI workup has low yield in this population without additional risk factors 3, 1

5. Be aware that CDC guidelines suggest adjusting hemoglobin thresholds for Black patients (0.8 g/dL lower for adults), though this remains controversial and is not universally adopted 6

If Iron Deficiency is Confirmed

Should testing confirm iron deficiency (normal hemoglobin electrophoresis, low transferrin saturation, no inflammation), a 3-week trial of oral iron can serve as both diagnostic and therapeutic 1. Response to therapy (hemoglobin increase of approximately 1 g/dL) confirms the diagnosis. Document menstrual history thoroughly, as this is the presumed source in premenopausal women without GI symptoms.